Afya (NASDAQ:AFYA) Cut to Buy at Wall Street Zen

Afya (NASDAQ:AFYA) was downgraded by Wall Street Zen from a “strong-buy” rating to a “buy” rating in a report released on Saturday.

Several other equities research analysts also recently commented on AFYA. JPMorgan Chase & Co. restated a “neutral” rating and issued a $22.00 price target (down previously from $24.50) on shares of Afya in a research report on Wednesday, January 7th. Zacks Research downgraded shares of Afya from a “hold” rating to a “strong sell” rating in a research note on Friday, January 9th. Weiss Ratings restated a “hold (c)” rating on shares of Afya in a report on Wednesday, January 21st. Sanford C. Bernstein raised Afya to a “market perform” rating in a research report on Friday, January 16th. Finally, UBS Group reissued a “neutral” rating and set a $16.00 price target (down from $18.00) on shares of Afya in a research report on Friday, January 16th. One research analyst has rated the stock with a Buy rating, five have issued a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $17.38.

Afya Price Performance

NASDAQ AFYA opened at $15.04 on Friday. The company has a current ratio of 0.98, a quick ratio of 0.98 and a debt-to-equity ratio of 0.21. Afya has a 1 year low of $13.12 and a 1 year high of $19.90. The company has a market cap of $1.41 billion, a PE ratio of 10.82, a PEG ratio of 0.55 and a beta of 0.53. The stock’s 50-day moving average price is $14.76 and its two-hundred day moving average price is $14.88.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the company. Militia Capital Partners LP acquired a new stake in shares of Afya during the 2nd quarter valued at about $71,000. Quantbot Technologies LP bought a new position in Afya during the second quarter valued at approximately $117,000. Van ECK Associates Corp lifted its stake in Afya by 15.7% in the third quarter. Van ECK Associates Corp now owns 10,170 shares of the company’s stock valued at $159,000 after acquiring an additional 1,377 shares during the last quarter. State of Wyoming acquired a new stake in Afya in the second quarter valued at approximately $164,000. Finally, Quadrature Capital Ltd bought a new stake in Afya in the second quarter worth approximately $181,000. 88.02% of the stock is owned by institutional investors and hedge funds.

Afya Company Profile

Afya Ltd. operates as a leading provider of medical education and training services in Brazil. The company offers a comprehensive suite of educational programs that span undergraduate medical degrees, residency exam preparation, continuing medical education (CME) and digital learning platforms. Through a network of partner institutions and its own campus operations, Afya supports students at every stage of the medical training continuum, from enrollment in medical schools to ongoing professional development for practicing physicians.

At the core of Afya’s offerings is its undergraduate medical program, delivered through a combination of in-person courses at affiliated campuses and fully digital curricula.